Benzinga's Top Upgrades, Downgrades For April 24, 2018

Top Upgrades

  • Susquehanna upgraded KeyCorp KEY from Neutral to Positive. KeyCorp shares rose 1.16 percent to $20.10 in pre-market trading.
  • Deutsche Bank upgraded Discovery, Inc. DISCA from Hold to Buy. Discovery shares rose 3.07 percent to $24.50 in pre-market trading.
  • Leerink Swann upgraded Cardinal Health, Inc. CAH from Market Perform to Outperform. Cardinal Health shares rose 0.24 percent to close at $62.22 on Monday.
  • Berenberg upgraded Emerson Electric Co. EMR from Sell to Hold. Emerson Electric shares fell 0.43 percent to close at $69.90 on Monday.
  • Analysts at Raymond James upgraded Cenovus Energy Inc. CVE from Underperform to Market Perform. Cenovus Energy shares fell 0.31 percent to close at $9.60 on Monday.
  • Deutsche Bank upgraded Fresenius Medical Care AG & Co. KGaA FMS from Hold to Buy. Fresenius Medical shares rose 3.39 percent to $50.87 in pre-market trading.
  • Goldman Sachs upgraded BP p.l.c. BP from Neutral to Buy. BP shares rose 1.14 percent to $44.42 in pre-market trading.
  • Needham upgraded Cadence Design Systems, Inc. CDNS from Hold to Buy. Cadence Design shares gained 12.03 percent to $41.16 in pre-market trading.
  • Loop Capital upgraded Hexcel Corporation HXL from Hold to Buy. Hexcel shares rose 0.54 percent to $65.40 in pre-market trading.


Top Downgrades

  • Citigroup downgraded Alcoa Corporation AA from Buy to Neutral. Alcoa shares fell 0.56 percent to $51.62 in pre-market trading.
  • Mizuho downgraded Skyworks Solutions, Inc. SWKS from Buy to Neutral. Skyworks shares fell 0.78 percent to $87.95 in pre-market trading.
  • Analysts at RBC Capital downgraded Vale S.A. VALE from Outperform to Sector Perform. VALE shares rose 0.07 percent to $13.75 in pre-market trading.
  • Raymond James downgraded Imperial Oil Limited IMO from Market Perform to Underperform. Imperial Oil shares rose 0.92 percent to close at $29.71 on Monday.
  • Wells Fargo downgraded Dynagas LNG Partners LP DLNG from Market Perform to Underperform. Dynagas LNG Partners shares dropped 5.06 percent to $9.00 in pre-market trading.
  • CL King downgraded Bojangles', Inc. BOJA from Buy to Neutral. Bojangles shares fell 0.67 percent to close at $14.80 on Monday.
  • BTIG Research downgraded Prothena Corporation plc PRTA from Buy to Neutral. Prothena shares rose 1.30 percent to $11.65 in pre-market trading.
  • Goldman Sachs downgraded Henry Schein, Inc. HSIC from Buy to Neutral. Henry Schein shares declined 1.34 percent to $72.80 in pre-market trading.


Top Initiations

  • Wells Fargo initiated coverage on The Home Depot, Inc. HD with an Outperform rating. The price target for Home Depot is set to $205. Home Depot shares closed at $177.66 on Monday.
  • Citigroup initiated coverage on iQIYI, Inc. IQ with a Buy rating. The price target for iQIYI is set to $22. iQIYI shares closed at $18.24 on Monday.
  • Maxim Group assumed coverage on Applied DNA Sciences, Inc. APDN with a Buy rating. The price target for Applied DNA Sciences is set to $5. Applied DNA Sciences shares closed at $1.44 on Monday.
  • Analysts at Wells Fargo initiated coverage on Lowe's Companies, Inc. LOW with an Outperform rating. The price target for Lowe's is set to $100. Lowe's shares closed at $84.35 on Monday.
  • Wells Fargo initiated coverage on AutoZone, Inc. AZO with an Outperform rating. The price target for AutoZone is set to $700. AutoZone shares closed at $599.47 on Monday.
  • Mizuho initiated coverage on First Data Corporation FDC with a Buy rating. The price target for First Data is set to $19. First Data shares closed at $15.14 on Monday.
  • Wells Fargo initiated coverage on Best Buy Co., Inc. BBY with a Market Perform rating. The price target for Best Buy is set to $77. Best Buy shares closed at $73.50 on Monday.
  • Analysts at Hovde Group initiated coverage on Nicolet Bankshares, Inc. NCBS with a Market Perform rating. Nicolet Bankshares closed at $56.88 on Monday.
  • Goldman Sachs initiated coverage on Alder Biopharmaceuticals, Inc. ALDR with a Neutral rating. The price target for Alder Biopharmaceuticals is set to $17. Alder Biopharmaceuticals shares closed at $13.65 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsConsumer DiscretionaryHome Improvement RetailInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!